May 13, 2022
Via: World Pharma NewsVaccines based on inactivated SARS-CoV-2 virus are commonly used in developing countries due to their low cost. New research from Karolinska Institutet in Sweden shows that a booster shot of mRNA vaccine to individuals who have received two doses of […]
May 6, 2022
Via: Drugs.comAn experimental COVID-19 vaccine in pill form could be a win-win, as it not only protects against infection but also limits the airborne spread of the virus, tests in lab animals show. The current vaccines reduce the risk of serious […]
May 6, 2022
Via: Biopharm InternationalFDA announced on May 5, 2022 that it has limited the emergency use authorization (EUA) of the Janssen COVID-19 vaccine to individuals 18 years of age and older for whom other authorized or approved COVID-19 vaccines are not accessible or […]
April 29, 2022
Via: Drugs.comNovavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) will review NVX-CoV2373 COVID-19 Vaccine (recombinant, […]
April 28, 2022
Via: Biopharma DiveFor parents of young children, the two-year pandemic has been especially tough. More than a year after vaccinations became routine for adults, they still have no options for their kids. Meanwhile, the FDA has been trying to speed the process […]
April 27, 2022
Via: Drugs.comBabies and toddlers who’ve been given antibiotics might have a less vigorous immune response to routine childhood vaccinations, new research warns. The study is the first to suggest that antibiotics might dampen youngsters’ ability to generate infection-fighting antibodies in response […]
FDA, Industry, Regulations, Vaccines
April 26, 2022
Via: FiercePharmaEven though most people in the U.S. have been eligible for COVID-19 vaccines and boosters for quite some time, children under 5 still don’t have vaccine options. Now, lawmakers are asking the FDA to lay out its plans in this […]
April 26, 2022
Via: Drugs.comPfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today submitted an application to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of a 10-µg booster dose of the Pfizer-BioNTech COVID-19 Vaccine for children 5 through […]
April 21, 2022
Via: Drugs.comA prior COVID-19 infection may provide unvaccinated adults with as much immunity against reinfection as the Pfizer-BioNTech or Moderna mRNA vaccines, new research suggests. However, the study was conducted before the surge of the highly transmissible Omicron variant. “We found […]
April 15, 2022
Via: FiercePharmaAs supplies of COVID-19 vaccines have become more plentiful in poor nations, many are tuning down certain shipments. A document from the World Health Organization’s global vaccine supply effort COVAX shows that low-income countries have declined millions of doses of […]
April 14, 2022
Via: FiercePharmaJust as Regeneron’s COVID-19 antibody combination, REGEN-COV, is sidelined in the U.S. thanks to omicron, the drug has hit a hiccup on its quest for a full FDA nod. The FDA has extended the review of REGEN-COV by three months […]
April 12, 2022
Via: FiercePharmaBioNTech has struck a deal to explore oral delivery of mRNA vaccines. Working with Matinas BioPharma, the German mRNA specialist will study the potential for a lipid nanocrystal (LNC) platform to enable new vaccine formulations. The pandemic catapulted BioNTech into […]
April 21, 2022
April 20, 2022
May 12, 2022
April 28, 2022
Copyright © 2022. All rights reserved
